Latest Disclosure Policy News

Page 1 of 11
SKS Technologies has denied knowledge of undisclosed information after ASX queried a sharp share price reversal and significant trading volume. The company said its projects, work in hand and data centre opportunity pipeline remained unchanged.
Victor Sage
Victor Sage
14 Oct 2026
333D Limited (ASX:T3D) has told the ASX it is unaware of any undisclosed information that could explain a sharp rise in its share price and trading volume. The company offered no alternative explanation for the move, which took its shares from $0.035 to an intraday high of $0.064.
Victor Sage
Victor Sage
5 Oct 2026
Suncorp Group has rejected speculation that it is in takeover discussions with Tokio Marine after its shares climbed from $19.05 to $20.18 and trading volumes increased. The insurer told the ASX it had received no takeover offer and knew of no undisclosed information explaining the move.
Claire Turing
Claire Turing
1 Oct 2026
BOA Resources says it is unaware of undisclosed information behind a sharp increase in trading, despite further Ricci Lee assay results remaining pending through October. The company attributed the move to investor reaction to its recent high-grade copper announcement.
Maxwell Dee
Maxwell Dee
25 Sept 2026
Bridge SaaS has told ASX it knows of no undisclosed information behind a sharp share price fall and significant increase in trading volume. The response confirms compliance with continuous disclosure rules but leaves the market activity unexplained.
Sophie Babbage
Sophie Babbage
17 Sept 2026
Tivan has won approval to add 50 square kilometres to its Baucau copper-gold project in Timor-Leste, securing ground over a large magnetic anomaly. The expansion comes as the company acknowledges an executive chairman’s personal X post previewed an assay announcement before ASX release and was not authorised under its disclosure policy.
Maxwell Dee
Maxwell Dee
15 Sept 2026
Actinogen Medical (ASX:ACW) has clarified that no undisclosed information explains recent unusual trading in its shares, pointing instead to recent underwriting of options and published updates. The biotech also reaffirmed compliance with ASX rules and provided a detailed update on its lead Alzheimer’s drug Xanamem and ongoing clinical trials.
Ada Torres
Ada Torres
4 Sept 2026
DroneShield Limited reported record revenue of $125.8 million for the half-year ended June 2026, driven by recurring income and geographic diversification, while posting a $32.2 million statutory loss due to margin pressure and strategic investments.
Sophie Babbage
Sophie Babbage
26 Aug 2026
Arrow Minerals revealed a previously confidential tenement acquisition following an ASX price query triggered by a sharp rise in its share price. The company attributes the price movement to multiple positive developments rather than the acquisition itself.
Maxwell Dee
Maxwell Dee
18 Aug 2026
Far East Gold Ltd (ASX: FEG) has explained the delayed filing of a director’s interest change notice, attributing the lag to the off-market takeover bid process by Xingye Gold. The company is reinforcing its disclosure policies to prevent future delays.
Maxwell Dee
Maxwell Dee
12 Aug 2026
Altech Batteries has officially ended its CERENERGY battery project and terminated its strategic partner search, responding to ASX queries about the timing of its disclosures following an unauthorized announcement by a related entity.
Maxwell Dee
Maxwell Dee
7 Aug 2026
American Tungsten & Antimony Ltd (ASX: AT4) affirmed the materiality of its US acquisition deal and detailed its adherence to ASX continuous disclosure rules following an ASX inquiry.
Maxwell Dee
Maxwell Dee
7 Aug 2026

Browse the archive

Full archive